Exploring Challenges in Diagnosis, Treatment of Asthma-COPD Overlap Syndrome | CHEST 2024
Two posters presented at the annual meeting of the American College of Chest Physicians, CHEST 2024, offered insights into the accurate diagnosis and appropriate treatment of ACOS.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Strategies for Success: How to Navigate the Evolving Health Care Landscape and Unlock Alternate Revenue Streams
Emily Endres, BSPS, vice president of pharmacy at PQS by Innovaccer, provides insights into the industry’s next phase.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Assessing the Efficacy of Mepolizumab in Asthma, COPD
Research Presented at CHEST 2024 reported on how mepolizumab can improve asthma control, and reduce exacerbations of concurrent asthma and COPD.
The Perils of Frivolous Lawsuits
Current rules governing lawsuits must be revisited to strike a balance between legitimate and frivolous legal actions against health care providers.
